logo
Select company
Select metric
$ 107.68MWorking Capital
VS
Market
55
Sector
55
Industry
56
History
52
$ 9.66Close
$ 3.99 - $ 45.62 52-Week Range
Ticker Information

Ticker

ALGS

Company Name

ALIGOS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALIGOS THERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALGS - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 127.94M$ 20.27M$ 107.68M
3/31/2025$ 143.21M$ 18.95M$ 124.26M
12/31/2024$ 62.14M$ 21.74M$ 40.4M
9/30/2024$ 79.82M$ 20.96M$ 58.87M
6/30/2024$ 99.57M$ 23.56M$ 76.01M
3/31/2024$ 118.06M$ 18.88M$ 99.18M
12/31/2023$ 141.08M$ 23.91M$ 117.18M
9/30/2023$ 74.64M$ 22.47M$ 52.17M
6/30/2023$ 94.24M$ 27.23M$ 67.02M
3/31/2023$ 109.43M$ 28.08M$ 81.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALIGOS THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 53.71M.
  • Over the past 5 years, ALIGOS THERAPEUTICS INC's average Working Capital has been $ 117.39M.
  • The median Working Capital for ALIGOS THERAPEUTICS INC during this period was $ 112.43M
  • ALIGOS THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 219.74M.
  • The lowest Working Capital recorded by ALIGOS THERAPEUTICS INC in the same timeframe $ 40.4M

ALIGOS THERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
STTK : SHATTUCK LABS INC $ 49.34MCAMP : CAMP4 THERAPEUTICS CORP $ 33.75MNRXS : NEURAXIS INC $ 4.27MPYXS : PYXIS ONCOLOGY INC $ 82.28MNTRB : NUTRIBAND INC $ 5.95MDTIL : PRECISION BIOSCIENCES INC $ 56.69MDYAI : DYADIC INTERNATIONAL INC $ 3.75MADVM : ADVERUM BIOTECHNOLOGIES INC $ 17.04MPSTV : PLUS THERAPEUTICS INC $ 1.9MPLUR : PLURI INC $ -10.23M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for ALIGOS THERAPEUTICS INC is calculated as follows: AssetsC [ $ 73.69M ] - LiabilitesC [ $ 19.98M ]
(=) Working Capital [ $ 53.71M ]

ALGS - Working Capital, Last 5 years

$ 40.4M

Minimum

Dec 31, 2024

$ 219.74M

Maximum

Dec 31, 2020

$ 117.39M

Average

$ 112.43M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -465.2M
max$ 607.04M
average$ 96.5M
median$ 32.21M
std$ 173.86M